Procure radiopharmaceutical products

Ended Awarded

Contract number
HT001426FE073
Awardee
Awarding agency
Obligated
$501,670

Award facts

Contract value 100% obligated
$501,669.60 Current and potential, with all options
Completion date
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a $501,669.60 ceiling delivery order to Novartis Pharmaceuticals Corporation, doing business as NPS, on July 9, 2026, under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule to procure radiopharmaceutical products. The order is firm fixed price and was issued with no set-aside. Place of performance is Bethesda, MD 20889, and the period of performance runs from the July 9, 2026 award to an ultimate completion date of July 9, 2026.

Quick answers

Who was awarded contract HT001426FE073?

HT001426FE073 was awarded to Novartis Pharmaceuticals Corporation by Defense Health Agency (Department of Defense) on July 9, 2026.

How much is contract HT001426FE073 worth?

The government has obligated $501,670 on HT001426FE073.

Is contract HT001426FE073 an order under another contract?

Yes. HT001426FE073 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract HT001426FE073 competed?

The extent of competition for HT001426FE073 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award